Targeted nanoparticle delivery of irinotecan enhances tumor response to PD-L1 blockade in colorectal cancer
{{output}}
Colorectal cancer (CRC) remains a leading cause of cancer mortality, with limited therapeutic options in advanced stages. CD44v6, a splice variant overexpressed in CRC, promotes tumor progression and immune evasion, representing a relevant target for selective... ...
